Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty research firms that are presently covering the firm, Marketbeat ...

Proficio Capital Partners LLC lifted its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 30.2% in the fourth quarter, Holdings Channel reports. The fund owned 6,739 shares of the company ...

Eli Lilly and Company discovers ... Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for ...

Eli Lilly bought a stake in Protomer Technologies ... It was also responsible for the first recombinant insulin product – Humulin – which launched in 1982 and remains on sale.

Eli Lilly and Boehringer Ingelheim will undercut Sanofi by 15% with Basaglar, a biosimilar version of the insulin blockbuster ... all versions of Humalog, all Humulin U100 formulations, as well ...

and Humulin for cardiometabolic; and Taltz and Olumiant for immunology. Following our analysis of the options activities associated with Eli Lilly, we pivot to a closer look at the company's own ...